WHO OKs New Genome Editing Registry, Calls For Governance Framework
Executive Summary
A new global registry is being set up to log all research involving genome editing, and there are plans for an online consultation on a governance framework on such research. The Alliance for Regenerative Medicine has welcomed the fact that the new registry will not be as burdensome for therapeutic developers as it originally thought.
You may also be interested in...
WHO's Human Genome Editing Standards Must Not Impact Somatic Cell Research
Concerns have been expressed that efforts by the World Health Organization to establish global standards for the whole spectrum of human genome editing research may inadvertently have a negative impact on companies developing somatic cell therapy medicinal products.
Post-Brexit UK Risks Being ‘Left Out In The Cold’ As EU Coordinates Action On Shortages
The UK is not alone in experiencing drug shortages, as data from across Europe show, but its departure from the EU makes it more difficult to respond to supply chain pressures, according to new research.
EU Countries Offered Funding To Contribute to African Regulatory Strengthening
Training projects are intended to strengthen the African regulatory environment, boost the capacity of the African Medicines Agency, facilitate regulatory reliance, and increase joint new drug assessments.